Introduction: Hazelnuts are a leading trigger of food allergy. To date, several molecular components of hazelnut are available for component-resolved diagnosis. However, little is known about how simultaneous sensitization to multiple allergens affects the severity of the hazelnut-induced reaction. In a previous study, our group demonstrated a lower risk of systemic reactions to peach in patients sensitized to both Pru p 3 and Pru p 1 than in the patient monosensitized to peach LTP. We aimed to assess whether this was also true in hazelnut allergy in a cohort of adult patients. Methods: Patients were selected based on a history of symptoms such as urticaria, vomiting, diarrhea, asthma, and anaphylaxis indicative of hazelnut IgE-mediated food allergy and graded according to a clinical severity scale. For all patients, specific IgE was determined for Cor a 1 and Cor a 8 and, for most patients, also Cor a 9. Patients were offered an oral food challenge in open format (OFC) with a cocoa-based roasted hazelnut spread on a voluntary basis in order to prescribe an appropriate diet. Results: A total of two hundred and fourteen patients were recruited. Among these, 43 patients were monosensitized to Cor a 8. One hundred and seventy-one patients were sensitized to Cor a 1 (79.9%), and, among them, 48/171 (28.1%) were also Cor a 8 positive. Cor a 9 was evaluated in 124/214 patients, testing positive in 21/124 (16.9%). Patients monosensitized to Cor a 8 experienced systemic reactions more frequently than those sensitized to Cor a 1 ± Cor a 8 (p < 0.00001), with significantly more severe reactions (p < 0.0005) and testing more frequently positive at OFC (p < 0.0001). Regarding Cor a 9, the sensitized patients were significantly younger (p = 0.0013) and showed reactions of similar severity to patients who tested Cor a 9 negative, and these reactions were milder than in patients monosensitized only to Cor a 8. Discussion/Conclusion: Sensitization to Cor a 1 seems to protect from the development of the severe systemic reactions induced by Cor a 8 sensitization, Cor a 9 does not influence the severity of symptoms in adult patients. The OFC with roasted hazelnut may help in dietary guidance.

1.
Clarke AE, Elliott SJ, St Pierre Y, Soller L, La Vieille S, Ben-Shoshan M. Temporal trends in prevalence of food allergy in Canada. J Allergy Clin Immunol Pract. 2020;8(4):1428–30.e5.
2.
Rangkakulnuwat P, Lao-Araya M. The prevalence and temporal trends of food allergy among preschool children in Northern Thailand between 2010 and 2019. World Allergy Organ J. 2021;14(10):100593.
3.
Ma Z, Chen L, Xian R, Fang H, Wang J, Hu Y. Time trends of childhood food allergy in China: three cross-sectional surveys in 1999, 2009, and 2019. Pediatr Allergy Immunol. 2021;32(5):1073–9.
4.
McWilliam V, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The prevalence of tree nut allergy: a systematic review. Curr Allergy Asthma Rep. 2015;15(9):54.
5.
Lyons SA, Clausen M, Knulst AC, Ballmer-Weber BK, Fernandez-Rivas M, Barreales L, et al. Prevalence of food sensitization and food allergy in children across Europe. J Allergy Clin Immunol Pract. 2020;8:2736–46.e9.
6.
Valcour A, Lidholm J, Borres MP, Hamilton RG. Sensitization profiles to hazelnut allergens across the United States. Ann Allergy Asthma Immunol. 2019;122(1):111–6.e1.
7.
Grabenhenrich L, Trendelenburg V, Bellach J, Yürek S, Reich A, Fiandor A, et al. Frequency of food allergy in school-aged children in eight European countries: the EuroPrevall-iFAAM birth cohort. Allergy Eur J Allergy Clin Immunol. 2020;75(9):2294–308.
8.
Available from: http://www.fao.org/faostat.
9.
Ahmet Semih Uzundumlu; Kurtoglu S, Serefoglu C. Zafer Algur the role of Turkey in the world hazelnut production and exporting Emirates. J Food Agicultural. 2022;34(2):117–27.
10.
Worldwide hazelnut market analysis &amp; projections (2019-2024): in terms of consumption, Europe is expected to register the highest CAGR, at 7.6% (prnewswire.com).
11.
Cetinkaya PG, Buyuktiryaki B, Soyer O, Sahiner UM, Sackesen C, Sekerel BE. Phenotypical characterization of tree nuts and peanut allergies in east Mediterranean children. Allergol Immunopathol. 2020;48(4):316–22.
12.
Calamelli E, Trozzo A, Di Blasi E, Serra L, Bottau P. Hazelnut allergy. Medicina. 2021;57(1):67.
13.
Lyons SA, Burney PGJ, Ballmer-Weber BK, Fernandez-Rivas M, Barreales L, Clausen M, et al. Food allergy in adults: substantial variation in prevalence and causative foods across Europe. J Allergy Clin Immunol Pract. 2019;7(6):1920–8.e11.
14.
Ortolani C, Ballmer-Weber BK, Hansen KS, Ispano M, Wüthrich B, Bindslev-Jensen C, et al. Hazelnut allergy: a double-blind, placebo-controlled food challenge multicenter study. J Allergy Clin Immunol. 2000;105(3):577–81.
15.
McWilliam VL, Perrett KP, Dang T, Peters RL. Prevalence and natural history of tree nut allergy. Ann Allergy Asthma Immunol. 2020;124(5):466–72.
16.
Moraly T, Pelletier de Chambure D, Verdun S, Preda C, Seynave M, Vilain AC, et al. Oral immunotherapy for hazelnut allergy: a single-center retrospective study on 100 patients. J Allergy Clin Immunol Pract. 2020;8(2):704–9.e4.
17.
Sabouraud M, Biermé P, André-Gomez SA, Villard-Truc F, Payot F, Corréard AK, et al. Real-life experience with hazelnut oral immunotherapy. Ann Allergy Asthma Immunol. 2022;128(4):432–8.
18.
Goodman RE, Breiteneder H. The WHO/IUIS allergen nomenclature. Allergy. 2019;74(3):429–31.
19.
Dramburg S, Hilger C, Santos A, de Las Vecillas L, Aalberse RC, Acevedo N, et al. EAACI molecular Allergology user’s guide 2.0. Pediatr Allergy Immunol. 2023;34(Suppl 28):e13854.
20.
Datema MR, van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, et al. Component-resolved diagnosis and beyond: multivariable regression models to predict severity of hazelnut allergy. Allergy. 2018;73(3):549–59.
21.
Pastorello EA, Vieths S, Pravettoni V, Farioli L, Trambaioli C, Fortunato D, et al. Identification of hazelnut major allergens in sensitive patients with positive double-blind, placebo-controlled food challenge results. J Allergy Clin Immunol. 2002;109(3):563–70.
22.
Lamberti C, Nebbia S, Antoniazzi S, Cirrincione S, Marengo E, Manfredi M, et al. Effect of hot air and infrared roasting on hazelnut allergenicity. Food Chem. 2021;342:128174–.
23.
Masthoff LJ, Hoff R, Verhoeckx KCM, Van Os-Medendorp H, Michelsen-Huisman A, Baumert JL, et al. A systematic review of the effect of thermal processing on the allergenicity of tree nuts. Allergy. 2013;68(8):983–93.
24.
Skypala IJ, Asero R, Barber D, Cecchi L, Diaz Perales A, Hoffmann-Sommergruber K, et al. Non-specific lipid-transfer proteins: allergen structure and function, cross-reactivity, sensitization, and epidemiology. Clin Transl Allergy. 2021;11(3):e12010.
25.
Valbuena T, Reche M, Marco G, Toboso I, Ringauf A, Thuissard-Vasallo IJ, et al. Storage proteins are driving pediatric hazelnut allergy in a lipid transfer protein-rich area. Foods. 2021;10:2463.
26.
Masthoff LJN, Mattsson L, Zuidmeer-Jongejan L, Lidholm J, Andersson K, Akkerdaas JH, et al. Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. J Allergy Clin Immunol. 2013;132(2):393–9.
27.
Masthoff LJN, Blom WM, Rubingh CM, Klemans RJB, Remington BC, Bruijnzeel-Koomen CAFM, et al. Sensitization to Cor a 9 or Cor a 14 has a strong impact on the distribution of thresholds to hazelnut. J Allergy Clin Immunol Pract. 2018;6:2112–4.e1.
28.
Andrews T, Banks JR. Sensitization to cor a 9 and cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. Pediatrics. 2014;134(Suppl 3):S152.
29.
Pastorello EA, Farioli L, Pravettoni V, Scibilia J, Mascheri A, Borgonovo L, et al. Pru p 3-sensitised Italian peach-allergic patients are less likely to develop severe symptoms when also presenting IgE antibodies to Pru p 1 and Pru p 4. Int Arch Allergy Immunol. 2011;156:362–72.
30.
Scala E, Till SJ, Asero R, Abeni D, Guerra EC, Pirrotta L, et al. Lipid transfer protein sensitization: reactivity profiles and clinical risk assessment in an Italian cohort. Allergy. 2015;70(8):933–43.
31.
Bogas G, Muñoz-Cano R, Mayorga C, Casas R, Bartra J, Pérez N, et al. Phenotyping peach-allergic patients sensitized to lipid transfer protein and analysing severity biomarkers. Allergy. 2020;75(12):3228–36.
32.
Flinterman AE, Akkerdaas JH, den Hartog Jager CF, Rigby NM, Fernandez-Rivas M, Hoekstra MO, et al. Lipid transfer protein-linked hazelnut allergy in children from a non-Mediterranean birch-endemic area. J Allergy Clin Immunol. 2008;121(2):423–8.e2.
33.
Carraro S, Berardi M, Bozzetto S, Baraldi E, Zanconato S. Cor a 14-specific IgE predicts symptomatic hazelnut allergy in children. Pediatr Allergy Immunol. 2016;27(3):322–4.
34.
Nilsson C, Berthold M, Mascialino B, Orme M, Sjölander S, Hamilton R. Allergen components in diagnosing childhood hazelnut allergy: systematic literature review and meta-analysis. Pediatr Allergy Immunol. 2020;31(2):186–96.
35.
Uotila R, Röntynen P, Pelkonen AS, Voutilainen H, Kaarina Kukkonen A, Mäkelä MJ. For hazelnut allergy, component testing of Cor a 9 and Cor a 14 is relevant also in birch-endemic areas. Allergy. 2020;75(11):2977–80.
36.
Gomez F, Bogas G, Gonzalez M, Campo P, Salas M, Diaz-Perales A, et al. The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions. Clin Exp Allergy. 2017;47(3):339–50.
You do not currently have access to this content.